Dennis Langer - Jan 1, 2023 Form 3/A - Amendment Insider Report for Quoin Pharmaceuticals, Ltd. (QNRX)

Role
Director
Signature
/s/ Dennis Langer
Stock symbol
QNRX
Transactions as of
Jan 1, 2023
Transactions value $
$0
Form type
3/A - Amendment
Date filed
3/7/2023, 06:13 PM
Date Of Original Report
Jan 3, 2023
Previous filing
Jun 30, 2022
Next filing
Oct 30, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding QNRX Share Option (right to buy) Jan 1, 2023 Ordinary Shares 64.3M $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person's original Form 3 incorrectly indicated the options vest in four equal annual installments beginning on April 12, 2023; however, the options vest in three equal annual installments beginning on April 12, 2023.